The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The Stress-inducted Proteins RTP801 and RTP801L Are Negative Regulators of the Mammalian Target of Rapamycin Pathway
Open accessAbstract
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an essential role in cell growth control. mTOR stimulates cell growth by phosphorylating p70 ribosomal S6 kinase (S6K) and eukaryote initiation factor 4E-binding protein 1 (4EBP1). The mTOR pathway is regulated by a wide variety of cellular signals, including mitogenic growth factors, nutrients, cellular energy levels, and stress conditions. Recent studies have proposed several mechanisms to explain how mTOR is regulated by growth factors and cellular energy levels. However, little is known as to how mTOR is regulated by stress conditions. We observed that two stress-induced proteins, RTP801/Redd1 and RTP801L/Redd2, potently inhibit signaling through mTOR. Our data support that RTP801 and RTP801L work downstream of AKT and upstream of TSC2 to inhibit mTOR functions. These results add a new dimension to mTOR pathway regulation and provide a possible molecular mechanism of how cellular stress conditions may regulate mTOR function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Redd1 is a new stress-induced protein and is known as a negative regulator of mTOR through TSC1/TSC2 complex [106–115].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Self-citationTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Self-citationRheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Self-citationManning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
The AMP-activated protein kinase pathway – new players upstream and downstream
Hardie, D. G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01540 · Cited by 1,163
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K. (2004) · Nature Genetics · doi:10.1038/ng1494 · Cited by 980
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Monfar, 1996, Mol. Endocrinol., 10, 1107
Cited by
Sorted by citations
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M., et al. (2008) · Science · doi:10.1126/science.1161566 · Cited by 1,686
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236
DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710
Hypoxia-induced energy stress regulates mRNA translation and cell growth
Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B., & Simon, M. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.010 · Cited by 607
Morrison, D. K. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.003 · Cited by 609
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
Tsun, Z.-Y., Bar-Peled, L., Chantranupong, L., Zoncu, R., Wang, T., Kim, C., Spooner, E., & Sabatini, D. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.016 · Cited by 565
Signalling to translation: How signal transduction pathways control the protein synthetic machinery
Proud, C. G. (2007) · Biochemical Journal · doi:10.1042/bj20070024 · Cited by 520
Land, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507
Gözüaçık, D., & Kimchi, A. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78006-1 · Cited by 447
Oxygen availability and metabolic adaptations
Nakazawa, M. S., Keith, B., & Simon, M. C. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.84 · Cited by 446
Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1
Sofer, A., Lei, K., Johannessen, C. M., & Ellisen, L. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5834-5845.2005 · Cited by 449
Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?
Corradetti, M. N., & Guan, K.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209885 · Cited by 396
Self-citationAkt-dependent and -independent mechanisms of mTOR regulation in cancer
Memmott, R. M., & Dennis, P. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.004 · Cited by 392
Identification of the circadian transcriptome in adult mouse skeletal muscle
McCarthy, J. J., Andrews, J. L., McDearmon, E. L., Campbell, K. S., Barber, B. K., Miller, B. H., Walker, J. R., Hogenesch, J. B., Takahashi, J. S., & Esser, K. A. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00066.2007 · Cited by 368
Nutrient Sensing, Metabolism, and Cell Growth Control
Yuan, H.-X., Xiong, Y., & Guan, K. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.019 · Cited by 376
Self-citationDrummond, M. J., Dreyer, H. C., Fry, C. S., Glynn, E. L., & Rasmussen, B. B. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91397.2008 · Cited by 322
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., & Yonezawa, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209882 · Cited by 301
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · APOPTOSIS · doi:10.1007/s10495-008-0309-3 · Cited by 300
REDD1 is essential for stress-induced synaptic loss and depressive behavior
Ota, K. T., Liu, R.-J., Voleti, B., Maldonado-Aviles, J. G., Duric, V., Iwata, M., Dutheil, S., Duman, C., Boikess, S., Lewis, D. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3513 · Cited by 267
Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1
Hobbs, R. M., Seandel, M., Falciatori, I., Rafii, S., & Pandolfi, P. P. (2010) · Cell · doi:10.1016/j.cell.2010.06.041 · Cited by 275
Li, Y., Wang, Y., Kim, E., Beemiller, P., Wang, C. Y., Swanson, J. A., You, M., & Guan, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705231200 · Cited by 269
Self-citationERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)
Carriere, A., Romeo, Y., Acosta-Jaquez, H. A., Moreau, J., Bonneil, E., Thibault, P., Fingar, D. C., & Roux, P. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159046 · Cited by 268
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
Zhu, Z., Yang, C., Iyaswamy, A., Krishnamoorthi, S., Sreenivasmurthy, S. G., Liu, J., Wang, Z., Tong, B. C., Song, J., Lu, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030728 · Cited by 268
Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l -DOPA–Induced Dyskinesia
Santini, E., Heiman, M., Greengard, P., Valjent, E., & Fisone, G. (2009) · Science Signaling · doi:10.1126/scisignal.2000308 · Cited by 272
Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms
Dunlop, E. A., & Tee, A. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.012 · Cited by 263
Wang, H., Kubica, N., Ellisen, L. W., Jefferson, L. S., & Kimball, S. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610023200 · Cited by 262
Amino Acid Signaling in TOR Activation
Kim, J., & Guan, K. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062209-094414 · Cited by 239
Self-citationYoshida, T., Mett, I. L., Bhunia, A. K., Bowman, J. C., Perez, M. J., Zhang, L., Gandjeva, A., Zhen, L., Chukwueke, U. N., Mao, T., et al. (2010) · Nature Medicine · doi:10.1038/nm.2157 · Cited by 234
Malagelada, C., Jin, Z. H., & Greene, L. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3928-08.2008 · Cited by 228
Connolly, E. P., Braunstein, S. E., Formenti, S. C., & Schneider, R. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3955-3965.2006 · Cited by 227
Neuronal intrinsic barriers for axon regeneration in the adult CNS
Sun, F., & He, Z. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.03.013 · Cited by 199
Qiao, S., Dennis, M. J., Song, X., Vadysirisack, D. D., Salunke, D., Nash, Z. M., Yang, Z., Liesa, M., Yoshioka, J., Matsuzawa, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8014 · Cited by 199
Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals
Miyazaki, M., & Esser, K. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91355.2008 · Cited by 204
Genome-wide screen of promoter methylation identifies novel markers in melanomaPreprint
Koga, Y., Pelizzola, M., Cheng, E., Krauthammer, M. O., Sznol, M., Ariyan, S., Narayan, D., Molinaro, A. M., Halaban, R., & Weissman, S. M. (2009) · Genome Research · doi:10.1101/gr.091447.109 · Cited by 197
Malagelada, C., Ryu, E. J., Biswas, S. C., Jackson-Lewis, V. R., & Greene, L. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3292-06.2006 · Cited by 190
Human Muscle Gene Expression following Resistance Exercise and Blood Flow Restriction
Drummond, M. J., Fujita, S., Abe, T., Dreyer, H. C., Volpi, E., & Rasmussen, B. B. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318160ff84 · Cited by 187
ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression
Whitney, M. L., Jefferson, L. S., & Kimball, S. R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.079 · Cited by 199
Lee, M. N., Ha, S. H., Kim, J. J., Koh, A., Lee, C. S., Kim, J. H., Jeon, H., Kim, D., Suh, P., & Ryu, S. H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00165-09 · Cited by 196
An overview on genus garcinia: phytochemical and therapeutical aspects
Hemshekhar, M., Sunitha, K. R., Santhosh, M. S., Devaraja, S., Kemparaju, K., Vishwanath, B. S., Niranjana, S. R., & Girish, K. S. (2011) · Phytochemistry Reviews · doi:10.1007/s11101-011-9207-3 · Cited by 182
Musa, J., Orth, M. F., Dallmayer, M., Baldauf, M. C., Pardo, C., Rotblat, B., Kirchner, T., Leprivier, G., & Grünewald, T. G. P. (2016) · Oncogene · doi:10.1038/onc.2015.515 · Cited by 175
Tang, G., Yue, Z., Tallóczy, Z., Hagemann, T. L., Cho, W., Messing, A., Sulzer, D., & Goldman, J. E. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn042 · Cited by 176
AMP‐activated protein kinase and cancer
Wang, W., & Guan, K. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01980.x · Cited by 167
Self-citationMammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders
Chong, Z. Z., Shang, Y., Zhang, L., Wang, S., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14787 · Cited by 149
DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer
Tirado-Hurtado, I., Fajardo, W., & Pinto, J. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00106 · Cited by 134
The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy
John, J. S. (2007) · Frontiers in bioscience · doi:10.2741/2714 · Cited by 135
Growth Control Under Stress: mTOR Regulation through the REDD1-TSC Pathway
Ellisen, L. W. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2139 · Cited by 131
Ohyashiki, J. H., Kobayashi, C., Hamamura, R., Okabe, S., Tauchi, T., & Ohyashiki, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01131.x · Cited by 130
Kimball, S., & Jefferson, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.137208 · Cited by 122
Signaling regulations of neuronal regenerative ability
Lü, Y., Belin, S., & He, Z. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.007 · Cited by 114
Dan, M., Xu, L., Shao, A., Cheng, X., Zhang, C., Yokel, R. A., Takemura, T., Hanagata, N., Niwa, M., & Watanabe, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s85265 · Cited by 112
Jin, H., Seo, S., Woo, S., Kim, E. S., Lee, H., Yoo, D., An, S., Choe, T., Lee, S., Hong, S., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.015 · Cited by 113
Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma
Kucejová, B., Peña‐Llopis, S., Yamasaki, T., Sivanand, S., Tran, T. A. T., Alexander, S., Wolff, N. C., Lotan, Y., Xie, X.-J., Kabbani, W., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0302 · Cited by 118
Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals
Tan, V. P., & Miyamoto, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.005 · Cited by 113
Schneider, A., Younis, R. H., & Gutkind, J. S. (2008) · Neoplasia · doi:10.1593/neo.08586 · Cited by 107
Phosphoinositide 3-kinases as drug targets in cancer
Stephens, L., WILLIAMS, R., & Hawkins, P. T. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.002 · Cited by 105
Gurda, D., Handschuh, L., Kotkowiak, W., & Jakubowski, H. (2015) · Amino Acids · doi:10.1007/s00726-015-1956-7 · Cited by 104
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Kolesnichenko, M., Hong, L., Liao, R., Vogt, P. K., & Sun, P. (2012) · Cell Cycle · doi:10.4161/cc.20683 · Cited by 123
Polman, J. A. E., Hunter, R. G., Speksnijder, N., van den Oever, J. M. E., Korobko, O. B., McEwen, B. S., de Kloet, E. R., & Datson, N. A. (2012) · Endocrinology · doi:10.1210/en.2012-1255 · Cited by 104
Álvarez-García, Ó., Matsuzaki, T., Olmer, M., Plate, L., Kelly, J. W., & Lotz, M. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40104 · Cited by 101
Drummond, M. J., Miyazaki, M., Dreyer, H. C., Pennings, B., Dhanani, S., Volpi, E., Esser, K. A., & Rasmussen, B. B. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90842.2008 · Cited by 100
Kimball, S. R., Do, A. N. D., Kutzler, L., Cavener, D. R., & Jefferson, L. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706643200 · Cited by 106
Knowles, L. M., Chen, Y., Osterman, A. L., & Smith, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803384200 · Cited by 100
Molitoris, J. K., McColl, K. S., Swerdlow, S., Matsuyama, M., Lam, M., Finkel, T. H., Matsuyama, S., & Distelhorst, C. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245423 · Cited by 96
Estep, P. W., Warner, J. B., & Bulyk, M. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005242 · Cited by 91
Meyer, L. H., Eckhoff, S. M., Queudeville, M., Kraus, J. M., Giordan, M., Stursberg, J., Zangrando, A., Vendramini, E., Möricke, A., Zimmermann, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.014 · Cited by 93
The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 91
Moberg, M., Apró, W., & Blomstrand, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00353.2011 · Cited by 93
Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
Maubant, S., Tesson, B. M., Maire, V., Ye, M., Rigaill, G. J., Gentien, D., Cruzalegui, F. H., Tucker, G. C., Roman‐Roman, S., & Dubois, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122333 · Cited by 85
Nishioka, C., Ikezoe, T., Yang, J., Koeffler, H. P., & Yokoyama, A. (2008) · Leukemia · doi:10.1038/leu.2008.243 · Cited by 86
Dennis, M. D., McGhee, N. K., Jefferson, L. S., & Kimball, S. R. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.038 · Cited by 86
Nguyen, Q. D., Schachar, R. A., Nduaka, C. I., Sperling, M., Klamerus, K. J., Chi-Burris, K., Yan, E., Paggiarino, D. A., Rosenblatt, I., Aitchison, R., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.043 · Cited by 84
Wolff, N. C., Vega-Rubín-de-Celis, S., Xie, X., Castrillón, D. H., Kabbani, W., & Brugarolas, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01393-10 · Cited by 86
King, F. W., Fong, S., Griffin, C. A., Shoemaker, M., Staub, R., Zhang, Y., Cohen, I. V., & Shtivelman, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007283 · Cited by 83
Structural Analysis and Functional Implications of the Negative mTORC1 Regulator REDD1,
Vega-Rubín-de-Celis, S., Abdallah, Z., Kinch, L. N., Grishin, N. V., Brugarolas, J., & Zhang, X. (2010) · Biochemistry · doi:10.1021/bi902135e · Cited by 81
REDD1 Is a Major Target of Testosterone Action in Preventing Dexamethasone-Induced Muscle Loss
Wu, Y., Zhao, W., Zhao, J., Zhang, Y., Qin, W., Pan, J., Bauman, W. A., Blitzer, R. D., & Cardozo, C. P. (2009) · Endocrinology · doi:10.1210/en.2009-0530 · Cited by 81
Protiva, P., Hopkins, M. E., Baggett, S., Yang, H., Lipkin, M., Holt, P. R., Kennelly, E. J., & Bernard, W. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23515 · Cited by 74
Lecane, P. S., Karaman, M. W., Sirisawad, M., Naumovski, L., Miller, R. A., Hacia, J. G., & Magda, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2754 · Cited by 75
Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice
Cheng, Y., Sun, M., Chen, L., Li, Y., Lin, L., Yao, B., Li, Z., Wang, Z., Chen, J. C., Miao, Z., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.061 · Cited by 74
Howard, E. E., Pasiakos, S. M., Fussell, M. A., & Rodriguez, N. R. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa015 · Cited by 75
Is REDD1 a metabolic double agent? Lessons from physiology and pathology
Britto, F. A., Dumas, K., Giorgetti‐Peraldi, S., Ollendorff, V., & Favier, F. B. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00340.2020 · Cited by 72
Paligenosis: Cellular Remodeling During Tissue Repair
Brown, J. W., Cho, C. J., & Mills, J. C. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-035954 · Cited by 68
Che‐1‐induced inhibition of mTOR pathway enables stress‐induced autophagy
Desantis, A., Bruno, T., Catena, V., Nicola, F. D., Goeman, F., Iezzi, S., Sorino, C., Ponzoni, M., Bossi, G., Federico, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489920 · Cited by 71
Redox Stress and the Contributions of BH3-Only Proteins to Infarction
Webster, K. A., Graham, R. M., Thompson, J. W., Spiga, M., Frazier, D. P., Wilson, A., & Bishopric, N. H. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1667 · Cited by 71
Smooth Muscle–like Cells in Pulmonary Lymphangioleiomyomatosis
Krymskaya, V. P. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200705-061vs · Cited by 69
14-3-3 Proteins are Regulators of Autophagy
Pozuelo-Rubio, M. (2012) · Cells · doi:10.3390/cells1040754 · Cited by 67
Yun, S.-M., Woo, S. H., Oh, S. T., Hong, S.-E., Choe, T., Ye, S., Kim, E., Seong, M. K., Kim, H., Noh, W. C., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.016 · Cited by 67
REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch
Miyazaki, M., & Esser, K. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00464.2008 · Cited by 69
Lin, L., Stringfield, T. M., Shi, X., & Chen, Y. (2005) · Biochemical Journal · doi:10.1042/bj20050553 · Cited by 70
Yun, Z., Yulin, T., Wang, Y., Wei, D., Yin, C., Xu, J.-H., Jiang, R., & Xu, X. (2019) · Cancer Science · doi:10.1111/cas.14110 · Cited by 65
Exploiting mTOR Signaling: A Novel Translatable Treatment Strategy for Traumatic Optic Neuropathy?
Morgan-Warren, P. J., Berry, M., Ahmed, Z., Scott, R. A. H., & Logan, A. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12803 · Cited by 63
REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury
Morquette, B., Morquette, P., Agostinone, J., Feinstein, E., McKinney, R. A., Kolta, A., & Di Polo, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.149 · Cited by 60
DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress
Simonson, B., Subramanya, V., Chan, M. C., Zhang, A., Franchino, H. A., Ottaviano, F. G., Mishra, M. K., Knight, A. C., Hunt, D., Ghiran, I. C., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf5967 · Cited by 62
Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
Tolentino, M. J., Dennrick, A., John, E. S., & Tolentino, M. S. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.961601 · Cited by 60
RTP801/REDD1 Regulates the Timing of Cortical Neurogenesis and Neuron Migration
Malagelada, C., López-Toledano, M. A., Willett, R. T., Jin, Z. H., Shelanski, M. L., & Greene, L. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4011-10.2011 · Cited by 60
Cam, M., Bid, H. K., Xiao, L., Zambetti, G. P., Houghton, P. J., & Çam, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530303 · Cited by 60
Álvarez-García, Ó., Olmer, M., Akagi, R., Akasaki, Y., Fisch, K. M., Shen, T., Su, A. I., & Lotz, M. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.04.015 · Cited by 60
Canal, M., Romaní-Aumedes, J., Martín‐Flores, N., Pérez-Fernández, V., & Malagelada, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00313 · Cited by 65
Gordon, B. S., Williamson, D. L., Lang, C. H., Jefferson, L. S., & Kimball, S. R. (2015) · Journal of Nutrition · doi:10.3945/jn.114.207621 · Cited by 58
Metadata
- Authors
- Corradetti, M. N., Inoki, K., & Guan, K.-L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Guan, Kun-Liang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 280
- Issue
- 11
- Pages
- 9769-9772
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2093341871
- Cited by
- 237
- References
- 37
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 9 · 2020: 7 · 2019: 5 · 2018: 5 · 2017: 8 · 2016: 11 · 2015: 18 · 2014: 17 · 2013: 14 · 2012: 16
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (5-T32-HD075005)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mTOR signaling, RTP801, REDD1, stress proteins, Akt, TSC2, p70 S6 kinase, 4E-BP1, cell growth regulation, cellular stress
- MeSH terms
- Animals, Hypoxia, Cell Line, DNA Damage, DNA-Binding Proteins, Gene Expression Regulation, Glucocorticoids, Humans, Models, Biological, Phosphorylation, Protein Kinases, Proteins, Retroviridae, Transcription Factors, Transfection, Protein Biosynthesis, RNA Interference, RNA, Small Interfering, Immunoprecipitation, Adaptor Proteins, Signal Transducing, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review